News

The FDA is phasing out an animal testing requirement for monoclonal antibody therapies in favor of testing drugs on ...
The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...
The Food and Drug Administration (FDA) announced Thursday it plans to phase out animal testing requirements for biological ...
PETA and other animal advocacy groups have praised the Trump administration for recent announcements to phase out animal ...
The FDA laid out a three-year roadmap to phase out animal toxicity testing in drug research. In addition to organoids and lab ...
The FDA announced a shift away from animal testing for drug approval, citing advanced alternatives like AI and organoids ...
This is a groundbreaking step toward advancing public health by using more effective and human-relevant methods instead of ...
The U.S. Food and Drug Administration announced it is shifting away from animal testing in the development of monoclonal ...
The FDA announced it will be reducing, refining and potentially replacing the animal testing requirement for the approval of ...
The initiative, which will start with monoclonal antibodies, is the first big regulatory shift from the FDA since Martin ...
On Thursday, shares in Charles River Laboratories, a leading contract research organizations that has stirred controversy over its use of non-human primates, plunged 28 percent after the FDA issued ...
Recursion Pharmaceuticals' stock is soaring today on news the FDA is planning on phasing out some animal testing, replacing ...